DM
CNCE

Deerfield Management’s Concert Pharmaceuticals, Inc. CNCE Stock Holding History

Deerfield Management’s Portfolio CNCE Stock Details CNCE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-617,649
Closed -$6.24M – 150
2014
Q2 		$6.24M Hold
617,649
– – 0.25% 84
2014
Q1 		$8.31M Buy
+617,649
New +$8.72M 0.34% 70

Other funds holding CNCE

BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EI
EAM Investors Solana Beach, California $866M AUM 377.14% 1-Year Est. Return
WSA
Wall Street Associates Lajolla, California $151M AUM 30.3% 1-Year Est. Return
GTC
Ghost Tree Capital New York $331M AUM 70.11% 1-Year Est. Return
SAM
Senzar Asset Management New York $34.7M AUM 0.56% 1-Year Est. Return
U
UBS Zurich, Switzerland $136B AUM 16.36% 1-Year Est. Return

Deerfield Management's CNCE Position: Q3 2014 in Review

Deerfield Management sold out of Concert Pharmaceuticals, Inc. (CNCE) in Q3 2014, closing a stake of 617,649 shares — an estimated $6.24M sold.

Deerfield Management first reported a position in CNCE in Q1 2014 and held it in 2 quarters. The position peaked at $8.31M in Q1 2014. 51 funds tracked by Wall St. Rank hold CNCE as of Q3 2014.

  • Deerfield Management reported no remaining Concert Pharmaceuticals, Inc. position as of Q3 2014 after selling out during the quarter.
  • Deerfield Management sold 617,649 Concert Pharmaceuticals, Inc. shares in Q3 2014, an estimated $6.24M.
  • Deerfield Management first reported a position in Concert Pharmaceuticals, Inc. in Q1 2014 and held it in 2 quarters.
  • Deerfield Management's Concert Pharmaceuticals, Inc. position peaked at $8.31M in Q1 2014.
  • 51 funds tracked by Wall St. Rank held Concert Pharmaceuticals, Inc. as of Q3 2014.

Based on Deerfield Management's 13F filing for Q3 2014, filed 14 Nov 2014.